Literature DB >> 15165106

Inhibitory effect of melatonin on the growth of H22 hepatocarcinoma cells by inducing apoptosis.

Li Qin1, Ximing Wang, Qiuhong Duan, Beibei Chen, Shanshu He.   

Abstract

Whether melatonin not only inhibits the growth of H22 hepatocarcinoma cells but also induces apoptosis in vitro was assessed. The anti-proliferative effects of melatonin on tumor cells was observed by MTT assay and tumor cells growth curve assay. And the apoptosis of the cells was studied by acridine orange fluorescence assay and flow cytometry. The cell cycle of the tumor cells was also observed by flow cytometry. It was found that melatonin could significantly inhibit the growth of H22 hepatocarcinoma cells. Incubated with melatonin, chromatin condensation of the tumor cells was observed by fluorescence microscopy. Compared with control, the percentage of apoptotic cells was increased, and the proportion of G0/S increased but that of G2/M decreased. It was suggested that melatonin could directly inhibit the growth of H22 hepatocarcinoma cells by inducing apoptosis and extending the length of cell cycle of the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15165106     DOI: 10.1007/bf02830696

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin.

Authors:  S Cos; J Recio; E J Sánchez-Barceló
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

2.  Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver.

Authors:  D Acuña-Castroviejo; R J Reiter; A Menéndez-Peláez; M I Pablos; A Burgos
Journal:  J Pineal Res       Date:  1994-03       Impact factor: 13.007

3.  Inhibition of malignant trophoblastic cell proliferation in vitro and in vivo by melatonin.

Authors:  S Y Shiu; S C Xi; J N Xu; L Mei; S F Pang; K M Yao; J T Wong
Journal:  Life Sci       Date:  2000-09-15       Impact factor: 5.037

4.  Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro.

Authors:  M D Mediavilla; S Cos; E J Sánchez-Barceló
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 5.  The oxidant/antioxidant network: role of melatonin.

Authors:  R J Reiter; D X Tan; J Cabrera; D D'Arpa; R M Sainz; J C Mayo; S Ramos
Journal:  Biol Signals Recept       Date:  1999 Jan-Apr

6.  Modulation of anticancer cytokines IL-2 and IL-12 by melatonin and the other pineal indoles 5-methoxytryptamine and 5-methoxytryptophol in the treatment of human neoplasms.

Authors:  P Lissoni
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

7.  Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells.

Authors:  M M Marelli; P Limonta; R Maggi; M Motta; R M Moretti
Journal:  Prostate       Date:  2000-11-01       Impact factor: 4.104

Review 8.  Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.

Authors:  David E Blask; Leonard A Sauer; Robert T Dauchy
Journal:  Curr Top Med Chem       Date:  2002-02       Impact factor: 3.295

  8 in total
  1 in total

1.  Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.

Authors:  Xin Long; Jian Wang; Jian-Ping Zhao; Hui-Fang Liang; Peng Zhu; Qi Cheng; Qian Chen; Yan-Hui Wu; Zhan-Guo Zhang; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.